Will Idera Pharmaceuticals (IDRA) Stock Sustain Today's Rally?

NEW YORK (TheStreet) -- Idera Pharmaceuticals  (IDRA) surged Tuesday on a positive day for healthcare stocks after the company had remained relatively flat since last week.

Idera rose 17.92% to $3.35 at 1:04 p.m. The stock opened at $2.86. 

The stock is trading in the middle of its 52-week range of 52 cents to $6.87. It had a range today of $2.86 to $3.48 as of 1:04 p.m.

Idera was one of the biggest gainers among healthcare stocks and helped lead the sector upward along with Allergan (AGN), which surged thanks to Pershing Square Capital Management, led by founder and CEO William Ackman, and Valeant Pharmaceuticals International's (VRX) joint effort to pursue a takeover of the company.

Must Read: Warren Buffett's 10 Favorite Growth Stocks

SELL NOW: If you own any of the 900 stocks that TheStreet Quant Ratings has identified as a 'Sell'...you could potentially lose EVERYTHING in the next 6-12 months. Learn more

IDRA Chart

IDRA data by YCharts

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%